Updated: Aug 18, 2008
Cnidaria (formerly Coelenterata) are in the phylum of aquatic invertebrates responsible for more envenomations than any other marine phylum. Close to 9000 species of Cnidaria are known, of which approximately 100 are toxic to humans. These animals have a gastrovascular cavity with a single opening used in digestion and circulation. Another characteristic feature is the presence of stinging cells or nematocysts. Human envenomations occur from all 4 classes in this phylum: (1) Hydrozoa (Portuguese man-of-war and fire coral), (2) Scyphozoa (true jellyfish), (3) Cubozoa (box jellyfish), and (4) Anthozoa (soft corals and sea anemones). Of the many toxic species, 3 species or conditions deserve attention because they are life-threatening or extremely common: the box jellyfish Chironex fleckeri, the carybdeid Carukia barnesi (Irukandji syndrome), and the bluebottle or Portuguese man-of-war.
The toxin of Cnidaria is located in cnidocytes, which are stinging cells composed of organelles called nematocysts. Nematocysts are present on the outer surfaces of tentacles or near the mouth. Nematocysts are contained within the cnidoblast or the outer capsule. On the external surface of the cnidoblast is the cnidocil (trigger point), which can be triggered by mechanical or chemical stimuli or may have remote and local control. At the base of the cnidocil is a hollow, coiled, sharp, threaded tube containing venom. The threaded tubes have denticles, which give the uncoiling thread cutting power like a drill. Extruded threads may reach up to 1 mm in length, a distance that is sufficient to penetrate the dermis of human skin. It is currently believed that the explosive release of the thread is caused by a sudden release of springlike tensions stored in the collagenous structural compartment. This is likely due to the sudden removal of bound calcium ions, resulting in a sudden increase in osmotic pressure in the capsular fluid.
The venom of many species is complex and largely unknown. The majority of toxins contain a complex mixture of polypeptides and proteins including (1) catecholamines, (2) histamine, (3) hyaluronidase, (4) fibrinolysins, (5) kinins, (6) phospholipases, and (7) various hemolytic, cardiotoxic, and dermatonecrotic toxins.
Hydrozoa class
The Hydrozoa class contains Physalia species (ie, Portuguese man-of-war or bluebottle) and hydroid corals. Portuguese man-of-war is not a true jellyfish but rather a siphonophore colony of hydrozoans with 4 different groups of animals. The result is a free-swimming organism with tentacles hanging from a gas-filled float, which acts as a sail, allowing wind-assisted travel. At least 2 Physalia species are of importance: (1) the larger Physalia physalis, which is found in the Atlantic Ocean from Nova Scotia to the Caribbean Sea; and (2) the smaller Physalia utriculus, which is found in the Pacific and Indian Oceans. Tentacles may reach up to 100 ft in length and contain up to a million nematocysts.
Detached tentacles on the beach are hazardous because they are capable of releasing venom for several weeks. Physalia species are one of the most commonly encountered marine envenomations in the United States and South Pacific. At least 3 confirmed deaths are attributed to P physalis.
Fire corals (Millepora) are typically encountered off the Florida coast and in the Caribbean and produce minimal toxicity, predominantly local pain.
Hydroid corals are sessile creatures that can attach to rocks, coral, seaweed, or pilings. A typical reaction is a mild stinging sensation with occasional development of burning pain and lymphadenopathy.
Scyphozoa class
The Scyphozoa class contains true jellyfish. In the United States, true jellyfish are the most common Cnidaria species to cause envenomation. Sea nettles Chrysaora species and Cyanea species are located along the Atlantic coast, with a high concentration near the Chesapeake Bay. Envenomations caused by organisms in the class Scyphozoa are less severe than those caused by Portuguese man-of-war.
Cubozoa class
The Cubozoa class contains the most toxic marine organisms, box jellyfish (Chironex fleckeri) and sea wasp (Chiropsalmus quadrigatus). The box jellyfish is the most dangerous jellyfish known with at least 67 deaths attributed to its envenoming. They are known to move into shallow waters in pursue of prey, thereby invading popular swimming areas. It is the only jellyfish with an antivenom. These animals are found in northern Australia and have not been reported in North American waters.
Carukia barnesi is also in this class and produces Irukandji syndrome. The mechanism of Irukandji syndrome is not known. Although only C barnesi is conclusively known to cause this condition, a number of other jellyfish are also likely responsible. The venom of C barnesi contains a sodium channel modulator that is linked to increased catecholamine release, which explains the early hyperadrenergic state demonstrated by these patients. The mechanism for cardiac dysfunction is yet to be elucidated as to whether it is the result of a myotoxin, due to excessive catecholamines, or both.
Anthozoa class
Anthozoa class contains sea anemones and corals. Most Anthozoa organisms are sessile creatures, and anemones found within the United States tidal zones have minimal toxicity. The sea anemone Phyllodiscus semoni (night or wasp-sea anemone) located in the Western Pacific Ocean is reported to cause fulminant dermatitis and acute renal failure in humans.
Corals
Corals are important components of living reefs. Risk of infection from a coral cut is of greater concern than the toxic effects of the coral.
Jellyfish envenomations occur in coastal areas of the United States, with highest frequency during summer. Envenomations by Physalia species are the most common jellyfish encounter prompting evaluation in the emergency department. Cases of seabather's eruption occur in clusters along the East Coast and Caribbean.
An estimated 40,000-50,000 marine envenomations occur annually. Approximately 10,000 Cnidaria envenomations occur each summer off of the east coast of Australia, the vast majority of which are due to Physalia species. Each season, the RoyalDarwinHospital in Australia treats more than 40 patients with jellyfish encounters. A prospective evaluation of envenomings from that hospital over a 12-month period from 1999-2000 revealed that 70% resulted from the box jellyfish.1 The remaining 30% mostly involved other Cubozoa species. This study may suggest that box jellyfish envenomings are common but also suggests the severity of the encounters. Many beaches in Australia have large amounts of vinegar placed in prominent positions along swimming beaches in jellyfish-endemic areas. This likely reduces the amount of emergency department visits for mild-to-moderate encounters.
Fatal envenomations due to box jellyfish occur in tropical waters of northern Australia. Fatalities have occurred rapidly, within 60 seconds, from this species. At least 67 deaths have been attributed to the box jellyfish.
At least 3 deaths have occurred due to Physalia species since 1989 in the United States.
In addition, a 4-year-old boy died within 40 minutes from an apparent envenoming by the jellyfish Chiropsalmus quadrigatus in the Gulf of Mexico.2
Most patients who develop Irukandji syndrome recover within 1-2 days, but 2 deaths were reported in Queensland, Australia, in 2002.
Patients have reported delayed hypersensitivity reactions as well as hypopigmented and hyperpigmented areas in the regions of the original tentacles.
No scientific data substantiate any differences in Cnidaria envenomation that are attributable to race.
No scientific data substantiate any differences in Cnidaria envenomation that are attributable to gender.
Although not well studied, a large number of pediatric cases are reported in the literature, likely due to the shallow water swimming. The smaller body mass and thinner skin may make infants and children more susceptible to jellyfish envenomations.
Contact with a Cnidaria is the cause of envenomation, although some patients have developed mild symptoms after ingestion of jellyfish.
| Anaphylaxis | Lionfish and Stonefish |
| Appendicitis, Acute | Octopus Envenomations |
| Bites, Animal | Snake Envenomations, Sea |
| Decompression Sickness | Stingray Envenomations |
| Echinoderm Envenomations |
Prehospital personnel and rescuers on scene need to protect themselves from injury and protect the patient from further injury. When entering the water for rescue, protective clothing with wet suits and gloves is ideal. “Stinger suits” are highly recommended if available.
A poison center toxicologist can be consulted for treatment advice and access to antivenom.
Analgesics and local anesthetics can be used to ameliorate pain associated with these bites. Antivenom exists for box jellyfish (C fleckeri). Chironex antivenom will cross react with Chiropsalmus species venom to prevent neurotoxic and myotoxic effects. However, it has not prevented cardiovascular effects in vivo. Antivenom is available in Australia and is produced by Commonwealth Serum Laboratories.
These agents neutralize toxins.
Box jellyfish antivenom is ovine-based concentrated immunoglobulins. Each ampule contains sufficient activity to neutralize 20,000 IV mouse doses of C fleckeri venom. Chironex antivenom will cross react with Chiropsalmus species venom to prevent neurotoxic and myotoxic effects. However, it has not prevented cardiovascular effects in vivo. Box jellyfish antivenom is available from Commonwealth Serum Laboratory in Melbourne, Australia.
3 ampules IV/IM over 5 min diluted in 1:10 normal saline 6 ampules can be given in cardiac arrest
<12 years: Not established
>12 years: Administer as in adults
None reported
Documented hypersensitivity to ovine serum (may still be indicated for severe envenomation, despite hypersensitivity)
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Anaphylaxis may occur; appropriate therapeutic agents for treatment of anaphylaxis should be ready for immediate use
O'Reilly GM, Isbister GK, Lawrie PM, et al. Prospective study of jellyfish stings from tropical Australia, including the major box jellyfish Chironex fleckeri. Med J Aust. Dec 3-17 2001;175(11-12):652-5. [Medline].
Bengtson K, Nichols MM, Schnadig V, et al. Sudden death in a child following jellyfish envenomation by Chiropsalmus quadrumanus. Case report and autopsy findings. JAMA. Sep 11 1991;266(10):1404-6. [Medline].
Auerbach PS. Marine envenomations. N Engl J Med. Aug 15 1991;325(7):486-93. [Medline].
Bailey PM, Little M, Jelinek GA, et al. Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies. Med J Aust. Jan 6 2003;178(1):34-7. [Medline].
Brown CK, Shepherd SM. Marine trauma, envenomations, and intoxications. Emerg Med Clin North Am. May 1992;10(2):385-408. [Medline].
Brush DE. Marine envenomations. In: Flomembaum N, Goldfrank LR, Howland MA, Lewin NA, Hoffman RS, Nelson LS. Goldfrank's Toxicologic Emergencies. 8th ed. New York, NY: McGraw-Hill; 2006:1629-1642.
Burnett JW, Calton GJ. Jellyfish envenomation syndromes updated. Ann Emerg Med. Sep 1987;16(9):1000-5. [Medline].
Burnett JW, Gable WD. A fatal jellyfish envenomation by the Portuguese man-o'war. Toxicon. 1989;27(7):823-4. [Medline].
Currie BJ. Marine antivenoms. J Toxicol Clin Toxicol. 2003;41(3):301-8. [Medline].
Currie BJ, Jacups SP. Prospective study of Chironex fleckeri and other box jellyfish stings in the "Top End" of Australia's Northern Territory. Med J Aust. Dec 5-19 2005;183(11-12):631-6. [Medline].
Fenner PJ, Hadok JC. Fatal envenomation by jellyfish causing Irukandji syndrome. Med J Aust. Oct 7 2002;177(7):362-3. [Medline].
Fenner PJ, Williamson J, Callanan VI, et al. Further understanding of, and a new treatment for, "Irukandji" (Carukia barnesi) stings. Med J Aust. Dec 1-15 1986;145(11-12):569, 572-4. [Medline].
Fenner PJ, Williamson JA. Worldwide deaths and severe envenomation from jellyfish stings. Med J Aust. Dec 2-16 1996;165(11-12):658-61. [Medline].
Fenner PJ, Williamson JA, Burnett JW, et al. The "Irukandji syndrome" and acute pulmonary oedema. Med J Aust. Aug 1 1988;149(3):150-6. [Medline].
Freudenthal AR, Joseph PR. Seabather's eruption. N Engl J Med. Aug 19 1993;329(8):542-4. [Medline].
Giordano AR, Vito L, Sardella PJ. Complication of a Portuguese man-of-war envenomation to the foot: a case report. J Foot Ankle Surg. Jul-Aug 2005;44(4):297-300. [Medline].
Flomembaum N, Goldfrank LR, Howland MA, Lewin NA, Hoffman RS, Nelson LS. Goldfrank's Toxicologic Emergencies. 8th ed. 2006.
Haddad L, Lee L. Toxic marine life. In: Clinical Management of Poisoning and Drug Overdose. 3rd ed. WB Saunders Co; 1998:386-399.
Kimball AB, Arambula KZ, Stauffer AR, et al. Efficacy of a jellyfish sting inhibitor in preventing jellyfish stings in normal volunteers. Wilderness Environ Med. Summer 2004;15(2):102-8. [Medline].
Kizer KW. Marine envenomations. J Toxicol Clin Toxicol. 1983-1984;21(4-5):527-55. [Medline].
Little M. Is there a role for the use of pressure immobilization bandages in the treatment of jellyfish envenomation in Australia?. Emerg Med (Fremantle). Jun 2002;14(2):171-4. [Medline].
Lumley J, Williamson JA, Fenner PJ, et al. Fatal envenomation by Chironex fleckeri, the north Australian box jellyfish: the continuing search for lethal mechanisms. Med J Aust. May 16 1988;148(10):527-34. [Medline].
McGoldrick J, Marx JA. Marine envenomations. Part 2: Invertebrates. J Emerg Med. Jan-Feb 1992;10(1):71-7. [Medline].
Mizuno M, Nozaki M, Morine N, et al. A protein toxin from the sea anemone Phyllodiscus semoni targets the kidney and causes a severe renal injury with predominant glomerular endothelial damage. Am J Pathol. Aug 2007;171(2):402-14. [Medline].
Nimorakiotakis B, Winkel KD. Marine envenomations. Part 1--Jellyfish. Aust Fam Physician. Dec 2003;32(12):969-74. [Medline].
Pearn J. The sea, stingers, and surgeons: the surgeon's role in prevention, first aid, and management of marine envenomations. J Pediatr Surg. Jan 1995;30(1):105-10. [Medline].
Perkins RA, Morgan SS. Poisoning, envenomation, and trauma from marine creatures. Am Fam Physician. Feb 15 2004;69(4):885-90. [Medline].
Stein MR, Marraccini JV, Rothschild NE, et al. Fatal Portuguese man-o'-war (Physalia physalis) envenomation. Ann Emerg Med. Mar 1989;18(3):312-5. [Medline].
Tibballs J. Australian venomous jellyfish, envenomation syndromes, toxins and therapy. Toxicon. Dec 1 2006;48(7):830-59. [Medline].
Watters MR, Stommel EW. Marine Neurotoxins: Envenomations and Contact Toxins. Curr Treat Options Neurol. Mar 2004;6(2):115-123. [Medline].
Weisman R. Marine animals. In: Goldfrank LR. Goldfranks's Toxicologic Emergencies. 5th ed. Appleton & Lange; 1994:1327-1332.
jellyfish envenomation, cnidaria envenomation, jellyfish sting, box jellyfish, aquatic invertebrates, Hydrozoa, Portuguese man-of-war, fire coral, Scyphozoa, true jellyfish, Cubozoa, Anthozoa, sea anemone, coelenterate envenomation,
G Patrick Daubert, MD, Assistant Professor, Assistant Medical Director, Sacramento Division, California Poison Control System; Director of Clinical and Medical Toxicology Education, Department of Emergency Medicine, University of California, Davis Medical Center
G Patrick Daubert, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Medical Toxicology, American Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Dana A Stearns, MD, Assistant Director of Undergraduate Education, Department of Emergency Medicine, Massachusetts General Hospital
Dana A Stearns, MD is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
A Antoine Kazzi, MD, Chair and Medical Director, Department of Emergency Medicine, American University of Beirut, Lebanon
A Antoine Kazzi, MD is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.
John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Scott H Plantz, MD, FAAEM, Associate Clinical Professor of Emergency Medicine, Rosalind Franklin University of Medicine and Science, Chicago Medical School; Medical Director, WeCare Med,Inc
Scott H Plantz, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.
The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors, Chanida Sintuu, MD, Allison J Richard, MD, and Jeffery R Tucker, MD, to the development and writing of this article.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)